“…In this study, we developed pH-responsive γ-cyclodextrin (γCD)-based nanoparticles (NPs) for delivery of topotecan (TPT, as a model antitumor drug) ( Figure 1a). First, we prepared γ-cyclodextrin (γCD) conjugated with phenylacetic acid (PA, as a hydrophobic moiety) [16][17][18][19][20][21], denoted as γCDP. The resulting γCDP was subsequently coupled with 2,3-dimethylmaleic anhydride (DMA, as a pH-responsive moiety) [22,23], poly(ethylene glycol) (PEG, as a colloidal stabilizer) [6,7,24], and transferrin (Tf, as a target protein for Tf receptor-positive tumor cells) [2,6,[25][26][27] (Figure 1b), denoted as γCDP-(DMA/PEG-Tf).…”